Vi Labs Funding, Investors & Competitors

Vi Labs has raised $147M across 3 funding rounds, most recently a $111M undisclosed-stage round in June 2024.

Last Vi Labs funding round

$111M

Undisclosed stage · Jun 2024

Cumulative funding Vi Labs raised

$147M

across 3 funding rounds

Key investors in Vi Labs

  • Square Peg Capital
  • Cerca Partners
  • Triventures
  • Wellborn Ventures
  • General Atlantic
  • New Era Capital Partners
  • World Trade Ventures
  • Savano Capital Partners

Vi Labs Overview

About Vi Labs

Vi develops productized artificial intelligence for healthcare and life-sciences enterprises. Its platform combines privacy-safe real-world health signals with applications for patient activation, personalized engagement, operational workflows and performance measurement. The company began with biosensing and a consumer AI fitness coach and has since expanded into enterprise software used across patient and care-team journeys.


Founded

2016

HQ

United StatesNew York City, NY

Website

vi.co

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Vi Labs Funding History

Vi Labs has raised a total of $147M across 3 funding rounds.

Vi Labs' first fundraising round was a $16M seed round in March 2016. The most recent completed round was a $111M undisclosed-stage round in June 2024.

Vi Labs funding rounds

Vi Labs funding rounds
DateStageInvestorsRaisedDeal Summary
Jun 2024Undisclosed stageGeneral Atlantic (lead); Alpha Partners; Savano Capital Partners$111MVi Labs, operating as Vi, is an enterprise artificial intelligence company that helps health organizations, life sciences companies and wellness businesses use data and AI to improve member outcomes and operating returns. In June 2024 the company completed a growth equity round of about $111 million, led by Savano Capital Partners, with participation from General Atlantic, Alpha Partners and Anfield. The company sells to healthcare and life sciences enterprises. The business grew out of the LifeBEAM wearable technology lineage and now sells a platform covering patient activation, engagement and operations. Vi Labs acquired the consumer insights firm Motus in December 2022.
Jun 2018Series AWellborn Ventures; New Era Capital Partners; FGI Capital Partners; Triventures; Square Peg Capital; Joy Ventures; Cerca Partners$20MVi, the company previously known as LifeBEAM, announced a USD 20 million financing on June 21, 2018. New Era Capital Partners participated alongside Square Peg Capital, Cerca Partners, Triventures, Wellborn Ventures, FGI Capital Partners and other investors. At the time, Vi marketed an artificial-intelligence fitness coach delivered through voice-enabled headphones and built on the company's earlier biosensing work. The financing was intended to expand Vi's consumer fitness business, broaden distribution and support the development of its artificial-intelligence software across additional connected audio products and partnerships. Contemporary health-technology and Israeli business coverage support the amount, date, company identity and investor list. The correct database participant is New Era Capital Partners rather than the unrelated New Era Ventures entity. This synopsis is confined to the June 2018 round and does not mix in later convertible financing, subsequent acquisitions or cumulative-funding estimates that do not describe this event.
Mar 2016SeedSquare Peg Capital (lead); Wellborn Ventures; Atomics 14 Ventures; Triventures; World Trade Ventures; Cerca Partners$16MVi Labs, founded in 2011 by Omri Joffe, develops an AI platform for digital health and fitness, providing personalized audio coaching, machine learning insights from connected devices, and an SDK for fitness brands. The platform processes data to enhance engagement, retention, and health outcomes for users and trainers. Square Peg Capital partnered with Vi Labs in 2016 in a pre-seed round, with additional investors including Atomics 14 Ventures, Cerca Partners, Triventures, Wellborn Ventures, and World Trade Ventures. The company has raised a total of approximately $157.6M to $41.09M across rounds, with later funding including a $20M convertible note in April 2024 and a September 2021 valuation of $225M. Vi Labs serves over 30 million members daily and acquired Motus Consumer Insights in December 2022.

Who has invested in Vi Labs?

12 investors have backed Vi Labs across its funding rounds, including Square Peg Capital, Cerca Partners, Triventures, Wellborn Ventures, General Atlantic and New Era Capital Partners.

Lead investors include General Atlantic and Square Peg Capital.


Vi Labs Investors

Investors in Vi Labs by funding rounds participated
InvestorHQRoundsRoleFirst check
Wellborn VenturesIsraelTel Aviv2ParticipantMar 2016
TriventuresIsraelHerzliya2ParticipantMar 2016
Square Peg CapitalAustraliaSydney2LeadMar 2016
Cerca PartnersIsraelRa'anana2ParticipantMar 2016
Alpha PartnersUnited StatesNew York City, NY1ParticipantJun 2024
Atomics 14 VenturesChinaTaipei1ParticipantMar 2016
New Era Capital PartnersIsraelTel Aviv1ParticipantJun 2018
FGI Capital PartnersJapanTokyo1ParticipantJun 2018
General AtlanticUnited StatesNew York City, NY1LeadJun 2024
World Trade VenturesUnited StatesNew York City, NY1ParticipantMar 2016

This data is available for Pro users. Sign up to see all 12 Vi Labs investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Vi Labs Competitors

Vi Labs competitors include listed companies like IQVIA, ICON plc and Privia Health, and private ones like Innovaccer, NantHealth and Unite Us.

Public and private companies comparable to Vi Labs
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$45B3.4x
ICON plcIrelandIrelandPublicly listed$8.3B$816M$15B2.2x
InnovaccerUnited StatesSan Francisco, CAPrivate$250M-$3.5B13.8x
Privia HealthUnited StatesUnited StatesPublicly listed$2.1B$44M$3.1B1.1x
NantHealthUnited StatesLos Angeles, CAPrivate$58M-$2B-
Unite UsUnited StatesNew York City, NYPrivate--$1.6B-

Vi Labs Public Comps

Vi Labs is still privately-owned, but its public comps include IDEXX Laboratories, Veeva, Roper Technologies, IQVIA, GE HealthCare, Revvity, Solventum, ICON plc, Pro Medicus and United Imaging.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
IDEXX Laboratories$4.3B$1.5B12.6x11.5x35.9x32.3x
Veeva$3.2B$965M13.2x11.8x43.6x25.9x
Roper Technologies$7.9B$3.2B7.2x6.7x17.9x17.0x
IQVIA$16B$3.4B3.6x3.4x17.2x14.7x
GE HealthCare$21B$3.7B2.2x2.1x12.0x11.6x
Revvity$2.9B$735M6.8x6.8x26.5x21.4x
Solventum$8.3B$2.5B2.4x2.4x7.9x9.9x
ICON plc$8.3B$816M2.2x2.2x22.1x13.3x

This data is available for Pro users. Sign up to see all Vi Labs competitors and their valuation data.

Start Free Trial

Common questions about Vi Labs

When was Vi Labs founded?Vi Labs was founded in 2016.
Where is Vi Labs headquartered?Vi Labs is headquartered in New York City, NY, United States.
Is Vi Labs publicly listed?No, Vi Labs is a private, VC-backed company.
How much funding has Vi Labs raised?Vi Labs has raised $147M across 3 funding rounds.
What was Vi Labs' last funding round?Vi Labs' last funding round was a $111M undisclosed-stage round in June 2024, led by General Atlantic.
Who are Vi Labs' investors?Vi Labs' investors include Wellborn Ventures, Triventures, Square Peg Capital, Cerca Partners, Alpha Partners, Atomics 14 Ventures, New Era Capital Partners, FGI Capital Partners, General Atlantic, World Trade Ventures and 2 others.
Which companies are comparable to Vi Labs?Companies comparable to Vi Labs include IQVIA, ICON plc, Innovaccer, Privia Health, NantHealth and Unite Us.

See companies similar to Vi Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial